Does Rallies show Form 4 insider transactions for LFST?

Yes. Rallies tracks LFST insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is LFST research on Rallies investment advice?

No. Rallies provides research, data, and educational context for LFST. It does not provide personalized investment advice.

LFST (LifeStance Health Group, Inc. Common Stock) Stock Analysis - Insider Trades

LifeStance Health Group, Inc. Common Stock (LFST) is a publicly traded Healthcare sector company. As of May 21, 2026, LFST trades at $7.68 with a market cap of $2.98B and a P/E ratio of 0.00. LFST moved -0.71% today. Year to date, LFST is +8.94%; over the trailing twelve months it is +31.73%. Its 52-week range spans $3.74 to $8.89. Analyst consensus is strong buy with an average price target of $10.11. Rallies surfaces LFST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading LFST stock inside the company?

Recent LFST insider activity includes Bessler Robert sold 287.52K, Bessler Robert sold 287.52K, Shuey Eric sold 243.36K, BLACK DARREN M. sold 5.90M, and TPG GP A, LLC sold 28.28M. Rallies tracks insider transaction dates, shares, prices, and estimated values.

LFST Key Metrics

Key financial metrics for LFST
Metric	Value
Price	$7.68
Market Cap	$2.98B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$8.89
52-Week Low	$3.74
Volume	2.43M
Avg Volume	0
Revenue (TTM)	$1.49B
Net Income	$23.20M
Gross Margin	0.00%

Recent LFST Insider Trades

Bessler Robert sold 287.52K (~$2.31M) on May 12, 2026.
Bessler Robert sold 287.52K (~$2.31M) on May 12, 2026.
Shuey Eric sold 243.36K (~$1.95M) on May 12, 2026.
BLACK DARREN M. sold 5.90M (~$47.32M) on May 12, 2026.
TPG GP A, LLC sold 28.28M (~$226.82M) on May 12, 2026.

Latest LFST News

LifeStance Health Prices 35M-Share Offering at $8.15, Plans 6M-Share Repurchase — May 8, 2026
LifeStance Health Shares Surge 20% on 21% Q1 Revenue Growth — May 7, 2026
LifeStance Health Q1 Revenue Up 21% to $403.5M; EBITDA Climbs 48% — May 7, 2026
LifeStance Data Shows 79% Anxiety, 73% Depression Improvement in 180,000 Patients — Apr 9, 2026
LifeStance Health Raises Price Target to $10 After 17% Q4 Revenue Growth — Feb 28, 2026

LFST Analyst Consensus

9 analysts cover LFST: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.11.

Common questions about LFST

Who is trading LFST stock inside the company?: Recent LFST insider activity includes Bessler Robert sold 287.52K, Bessler Robert sold 287.52K, Shuey Eric sold 243.36K, BLACK DARREN M. sold 5.90M, and TPG GP A, LLC sold 28.28M. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for LFST?: Yes. Rallies tracks LFST insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is LFST research on Rallies investment advice?: No. Rallies provides research, data, and educational context for LFST. It does not provide personalized investment advice.